ACS Medicinal Chemistry Letters p. 678 - 681 (2017)
Update date:2022-07-30
Topics:
Qian, Hai-Yan
Wang, Zhi-Long
Pan, You-Lu
Chen, Li-Li
Xie, Xin
Chen, Jian-Zhong
Starting from a prototypical structure 1, we describe our efforts to design and obtain novel quinazoline/pyrimidine-2,4(1H,3H)-diones with high CB2 agonist potency and selectivity as well as improved physicochemical characteristics, mainly hydrophilicity. The most potent and selective CB2 agonists, 8 and 36, in this series were also endowed with lower logP values than that of GW842166X and lead compound 1. These derivatives appear to be promising lead compounds for the development of future CB2 agonists.
View MoreGuangxi Nanning Guangtai Agriculture Chemical Co.,Ltd
Contact:+86-771-2311266
Address:Room703,Building12, Software Park Phase II,NO.68,Keyuan Road,Nanning City,Guangxi,China
Ji'an Hairui Natural Plant Co. Ltd.
Contact:0796-8105528
Address:Meilin industry park, Qingyuan district Ji'an City, Jiangxi Province
Contact:(1) 206-3550089
Address:5115 NE 8TH PL, Renton, WA 98059 USA
Suzhou Health Chemicals Co., Ltd.
website:http://www.healthchems.com
Contact:13776257979
Address:No. 338, Jingang Avenue,
FOSHAN NANHAI ZHONGNAN PHARMACEUTICAL FACTORY
Contact:0086-0757-85609331
Address:XIAHENGTIAN INDUSTRIAL ZONE,SHAYONG VILLAGE,LISHUI TOWN
Doi:10.1016/j.poly.2006.06.036
(2007)Doi:10.1021/ic061883j
(2007)Doi:10.1039/C7OB00205J
(2017)Doi:10.1007/s11172-006-0153-y
(2005)Doi:10.1134/S1070428002120126
(2006)Doi:10.1021/jo00371a008
(1986)
